ABCL
AbCellera Biologics, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$12.27
−6.19%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 108.70x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.44x
- Price / sales
- 60.09x
- Price / cash flow
- -25.70x
Enterprise value
- Enterprise value
- $3.6B
- EV / sales
- 53.97x
- EV / EBITDA
- -21.14x
- EV / EBIT
- -15.86x
- Market cap
- $4.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026